AUSTIN, Texas, May 9 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) will present at the Bank of America Health Care Conference in Las Vegas at the Four Seasons Hotel on Tuesday, May 16, 2006. William W. Burke, Executive Vice President and Chief Financial Officer, will present at 8:00 a.m. Pacific time. The presentation will provide an overview of Encore's products, market opportunities and competitive position. A live audio webcast of the presentation will be accessible through Encore Medical Corporation's Web site at http://www.encoremed.com/ . The webcast will be available for two weeks following the presentation. Encore Medical Corporation is a diversified orthopedic device company that develops, manufactures and distributes a comprehensive range of high quality orthopedic devices used by orthopedic surgeons, physicians, therapists, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events and sports-related injuries. Through its Orthopedic Rehabilitation Division, Encore is a leading distributor of electrical stimulation and other orthopedic products used for pain management, orthopedic rehabilitation, physical therapy, fitness and sport performance enhancement. Encore's Surgical Implant Division offers a comprehensive suite of reconstructive joint products and spinal implants. For more information, visit http://www.encoremed.com/ . Contact: William W. Burke, Executive Vice President - Chief Financial Officer (512) 832-9500 Media: Davis Henley, Vice President - Business Development (512) 832-9500 Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties, such as quarterly fluctuations in operating results, the timely availability of new products, the impacts of competitive products and pricing, the ability to grow the distribution networks for the Company's products, the ability to continue to obtain long- term financing, and the ability to locate and integrate past and future acquisitions and other risks and uncertainties set forth in the Company's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein. DATASOURCE: Encore Medical Corporation CONTACT: William W. Burke, Executive Vice President - Chief Financial Officer, , or media, Davis Henley, Vice President - Business Development, , both of Encore Medical Corporation, +1-512-832-9500 Web site: http://www.encoremed.com/

Copyright

Encore Medical (NASDAQ:ENMC)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 Encore Medical 차트를 더 보려면 여기를 클릭.
Encore Medical (NASDAQ:ENMC)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 Encore Medical 차트를 더 보려면 여기를 클릭.